Ledger.Open graph →
SEC Form D · filed January 5, 2018

Cage Pharmaceuticals, Inc

Offering
$1.7M
Sold
$350K
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BALTIMORE, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Jason Rifkin · Scarsdale, NYExecGary J. Kurtzman · Boston, MAExecAshley Mcgrath · Kelowna, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗